Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgia Metzgeroth

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Leukemia|January 13, 2019
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosisMohamad Jawhar, Konstanze Döhner, Sebastian Kreil, et al.
Leukemia|March 10, 2026
Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?Dorothée Selimoglu-Buet, Sylvie Chevret, Valeria Santini, et al.
Blood|June 9, 2016
Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failureMaximilian Mossner, Johann-Christoph Jann, Janina Wittig, et al.
Annals of Hematology|July 21, 2017
Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phaseMohamad Jawhar, Nicole Naumann, Juliana Schwaab, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2019
MARS: Mutation-Adjusted Risk Score for Advanced Systemic MastocytosisMohamad Jawhar, Juliana Schwaab, Iván Álvarez-Twose, et al.
Nature Communications|November 30, 2021
Bone marrow sinusoidal endothelium controls terminal erythroid differentiation and reticulocyte maturationJoschka Heil, Victor Olsavszky, Katrin Busch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2022
Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO NetworkRaphael Itzykson, Valeria Santini, Sylvain Thepot, et al.
Nature Communications|March 18, 2023
Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignanciesQingyu Xu, Alexander Streuer, Johann-Christoph Jann, et al.
Leukemia|September 7, 2022
Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms - results of the EUROPE trial by EMSCOAnne Sophie Kubasch, Aristoteles Giagounidis, Georgia Metzgeroth, et al.
Haematologica|November 2, 2023
<i>ASXL1</i> mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasmsVladimir Riabov, Qingyu Xu, Nanni Schmitt, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Leukemia|January 13, 2019
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosisMohamad Jawhar, Konstanze Döhner, Sebastian Kreil, et al.
Leukemia|March 10, 2026
Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?Dorothée Selimoglu-Buet, Sylvie Chevret, Valeria Santini, et al.
Blood|June 9, 2016
Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failureMaximilian Mossner, Johann-Christoph Jann, Janina Wittig, et al.
Annals of Hematology|July 21, 2017
Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phaseMohamad Jawhar, Nicole Naumann, Juliana Schwaab, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2019
MARS: Mutation-Adjusted Risk Score for Advanced Systemic MastocytosisMohamad Jawhar, Juliana Schwaab, Iván Álvarez-Twose, et al.
Nature Communications|November 30, 2021
Bone marrow sinusoidal endothelium controls terminal erythroid differentiation and reticulocyte maturationJoschka Heil, Victor Olsavszky, Katrin Busch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2022
Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO NetworkRaphael Itzykson, Valeria Santini, Sylvain Thepot, et al.
Nature Communications|March 18, 2023
Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignanciesQingyu Xu, Alexander Streuer, Johann-Christoph Jann, et al.
Leukemia|September 7, 2022
Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms - results of the EUROPE trial by EMSCOAnne Sophie Kubasch, Aristoteles Giagounidis, Georgia Metzgeroth, et al.
Haematologica|November 2, 2023
<i>ASXL1</i> mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasmsVladimir Riabov, Qingyu Xu, Nanni Schmitt, et al.
Pageof 9